GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Emotra AB (XSAT:EMOT BTA) » Definitions » Cash-to-Debt

Emotra AB (XSAT:EMOT BTA) Cash-to-Debt : No Debt (1) (As of Sep. 2021)


View and export this data going back to . Start your Free Trial

What is Emotra AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Emotra AB's cash to debt ratio for the quarter that ended in Sep. 2021 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Emotra AB could pay off its debt using the cash in hand for the quarter that ended in Sep. 2021.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Emotra AB's Cash-to-Debt or its related term are showing as below:

XSAT:EMOT BTA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0   Med: No Debt   Max: No Debt
Current: No Debt

During the past 12 years, Emotra AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was No Debt.

XSAT:EMOT BTA's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.9 vs XSAT:EMOT BTA: No Debt

Emotra AB Cash-to-Debt Historical Data

The historical data trend for Emotra AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Emotra AB Cash-to-Debt Chart

Emotra AB Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.61 235.74 No Debt No Debt No Debt

Emotra AB Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt N/A No Debt

Competitive Comparison of Emotra AB's Cash-to-Debt

For the Medical Devices subindustry, Emotra AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emotra AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Emotra AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Emotra AB's Cash-to-Debt falls into.



Emotra AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Emotra AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2020 is calculated as:

Emotra AB had no debt (1).

Emotra AB's Cash to Debt Ratio for the quarter that ended in Sep. 2021 is calculated as:

Emotra AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emotra AB  (XSAT:EMOT BTA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Emotra AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Emotra AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Emotra AB (XSAT:EMOT BTA) Business Description

Traded in Other Exchanges
N/A
Address
Goteborgsvagen 74, Savedalen, SWE, 433 63
Emotra AB is engaged in developing medical devices for safe measurements of peripheral psychophysiological signals from the skin. The company provides information about psychological conditions and reaction.

Emotra AB (XSAT:EMOT BTA) Headlines

No Headlines